4.13 RXA SEGMENT USAGE IN VACCINE MESSAGES
Figure 4-21. RXA attributes usage
SEQ |
LEN |
DT |
OPT |
RP/# |
TBL# |
ITEM # |
ELEMENT NAME |
1 |
4 |
NM |
R |
00342 |
Give Sub-ID Counter |
||
2 |
4 |
NM |
R |
00344 |
Administration Sub-ID Counter |
||
3 |
26 |
TS |
R |
00345 |
Date/Time Start of Administration |
||
4 |
26 |
TS |
R |
00346 |
Date/Time End of Administration |
||
5 |
100 |
CE |
R |
0292 |
00347 |
Administered Code |
|
6 |
20 |
NM |
R |
00348 |
Administered Amount |
||
7 |
60 |
CE |
C |
00349 |
Administered Units |
||
8 |
60 |
CE |
O |
00350 |
Administered Dosage Form |
||
9 |
200 |
CE |
O |
Y |
00351 |
Administration Notes |
|
10 |
200 |
XCN |
O |
00352 |
Administering Provider |
||
11 |
200 |
CM |
C |
00353 |
Administered-at Location |
||
12 |
20 |
ST |
C |
00354 |
Administered Per (Time Unit) |
||
13 |
20 |
NM |
O |
01134 |
Administered Strength |
||
14 |
60 |
CE |
O |
01135 |
Administered Strength Units |
||
15 |
20 |
ST |
O |
Y |
01129 |
Substance Lot Number |
|
16 |
26 |
TS |
O |
Y |
01130 |
Substance Expiration Date |
|
17 |
60 |
CE |
O |
Y |
0227 |
01131 |
Substance Manufacturer Name |
18 |
200 |
CE |
O |
Y |
01136 |
Substance Refusal Reason |
|
19 |
200 |
CE |
O |
Y |
01123 |
Indication |
|
20 |
2 |
ID |
O |
0322 |
01223 |
Completion Status |
|
21 |
2 |
ID |
O |
0323 |
01224 |
Action Code |
|
22 |
26 |
TS |
O |
01225 |
System Entry Date/Time |